Dementia Big
Eli Lilly said Tuesday that it’s changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer’s disease, solanezumab.
http://ift.tt/22lMHsT
Wednesday, March 16, 2016
Eli Lilly changes outcome goals in Alzheimer's drug study
Eli Lilly changes outcome goals in Alzheimer's drug study:
http://ift.tt/22lMHsT
http://ift.tt/22lMHsT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment